Kidney Disease Clinical Trials in Chicago

Showing 381-400 of 407 trials

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

NCT00486538

This study is designed to determine the clinical efficacy and toxicity of ABT 869 in the treatment of subjects with advanced renal cell carcinoma who have previously received treatment with sunitinib.

Advanced Renal Cell Carcinoma

AbbVie (prior sponsor, Abbott)53 participantsStarted Jun 2007

Sacramento, California, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +10 more locations

COMPLETEDPhase 22.2 miles

S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

NCT00014144

RATIONALE: Biological therapies such as ZD 1839 may interfere with the growth of the tumor cells and slow the growth of cancer of the urinary tract. PURPOSE: Phase II trial to study the effectiveness of ZD 1839 in treating patients who have advanced cancer of the urinary tract.

Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer

SWOG Cancer Research Network31 participantsStarted Feb 2001

Birmingham, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +92 more locations

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

Kidney Disease Trials in Other Cities

Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Dialysis Catheter Comparative Clinical Trial

A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

Optimizing Prograf® Therapy in Renal Transplant Patients

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)

Post-Market Observational Study of Intra-Renal Drug Delivery

A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function

A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Clinical Evaluation of NeoPlex4 Assay and NeoPlex System

Other Conditions in Chicago